Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Full Video Transcript

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon May 19, 2023 9:22am

194 Views

Post# 35456192

RE:Full Video Transcript

Any idea why he'd only mention the 90 day CR% ? Probably due to such a small sample size in the longer timeframes? But if it's good enough for a press release, then why not mention the 450 day in the interview? The numbers are what they are. I suppose he's being conservative, doesn't want to put his foot in his mouth if the longer term numbers degrade as the sample size increases. Can't think of another reason he'd choose not to mention it, playing it safe I assume.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario